Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: To combat invading pathogens, cells develop an adaptive immune response by changing their own genetic information. In vertebrates, the generation of genetic variation (somatic hypermutation) is an essential process for diversification and affinity maturation of antibodies that function to detect and sequester various foreign biomolecules. The activation-induced cytidine deaminase (AID) carries out hypermutation by modifying deoxycytidine bases in the variable region of the immunoglobulin locus that produces antibody. AID-generated deoxyuridine in DNA is mutagenic as it can be miss-recognized as deoxythymine, resulting in C to T mutations. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) is a prokaryotic adaptive immune system that records and degrades invasive foreign DNA or RNA. The CRISPR/Cas system cleaves and incorporates foreign DNA/RNA segments into the genomic region called the CRISPR array. The CRISPR array is transcribed to produce crispr-RNA that serves as guide RNA (gRNA) for recognition of the complementary foreign DNA/RNA in a ribonucleoprotein complex with Cas proteins, which degrade the target. The CRISPR/Cas system has been repurposed as a powerful genome editing tool, because it can be programmed to cleave specific DNA sequence by providing custom gRNAs. RATIONALE: Although the precise mechanism by which AID specifically mutates the immunoglobulin locus remains elusive, targeting of AID activity is facilitated by the formation of a single-stranded DNA region, such as a transcriptional RNA/DNA hybrid (R-loop). The CRISPR/Cas system can be engineered to be nuclease-inactive. The nuclease-inactive form is capable of unfolding the DNA double strand in a protospacer adjacent motif (PAM) sequence-dependent manner so that the gRNA binds to complementary target DNA strand and forms an R-loop. The nuclease-deficient CRISPR/Cas system may serve as a suitable DNA-targeting module for AID to catalyze site-specific mutagenesis. RESULTS: To determine whether AID activity can be specifically targeted by the CRISPR/Cas system, we combined dCas9 (a nuclease-deficient mutant of Cas9) from Streptococcus pyogenes and an AID ortholog, PmCDA1 from sea lamprey, to form a synthetic complex (Target-AID) by either engineering a fusion between the two proteins or attaching a SH3 (Src 3 homology) domain to the C terminus of dCas9 and a SHL (SH3 interaction ligand) to the C terminus of PmCDA1. Both of these complexes performed highly efficient site-directed mutagenesis. The mutational spectrum was analyzed in yeast and demonstrated that point mutations were dominantly induced at cytosines within the range of three to five bases surrounding the –18 position upstream of the PAM sequence on the noncomplementary strand to gRNA. The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced in the Target-AID complexes. Combination of PmCDA1 with the nickase Cas9(D10A) mutant, which retains cleavage activity for noncomplementary single-stranded DNA, was more efficient in yeast but also induced deletions as well as point mutations in mammalian cells. Addition of the uracil DNA glycosylase inhibitor protein, which blocks the initial step of the uracil base excision repair pathway, suppressed collateral deletions and further improved targeting efficiency. Potential off-target effects were assessed by whole-genome sequencing of yeast as well as deep sequencing of mammalian cells for regions that contain mismatched target sequences. These results showed that off-target effects were comparable to those of conventional CRISPR/Cas systems, with a reduced risk of indel formation. CONCLUSION: By expanding the genome editing potential of the CRISPR/Cas9 system by deaminase-mediated hypermutation, Target-AID demonstrated a very narrow range of targeted nucleotide substitution without the use of template DNA. Nickase Cas9 and uracil DNA glycosylase inhibitor protein can be used to boost the targeting efficiency. The reduced cytotoxicity will be beneficial for use in cells that are sensitive to artificial nucleases. Use of other types of nucleotide-modifying enzymes and/or other CRISPR-related systems with different PAM requirements will expand our genome-editing repertoire and capacity. A crippled CRISPR/Cas targets AID.: In vertebrate adaptive immunity, cytosine deaminase (AID or PmCDA1) induces somatic hypermutation at single-stranded DNA regions formed during transcription. The bacterial CRISPR/Cas9 immunity system recognizes and cleaves invasive DNA in a gRNA-dependent manner. AID and nuclease-deficient CRISPR/Cas9 are engineered to form a hybrid complex (Target-AID) that performs programmable cytosine mutations in a range of a few bases surrounding the –18 position upstream of PAM sequence of the noncomplementary DNA strand.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems
DiCarlo, J. E., Norville, J. E., Mali, P., Rios, X., Aach, J., & Church, G. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt135 · Cited by 1,566
Synthetic protein scaffolds provide modular control over metabolic flux
Dueber, J. E., Wu, G. C., Malmirchegini, G. R., Moon, T. S., Petzold, C. J., Ullal, A. V., Prather, K. L. J., & Keasling, J. D. (2009) · Nature Biotechnology · doi:10.1038/nbt.1557 · Cited by 1,242
Cas9 as a versatile tool for engineering biology
Mali, P., Esvelt, K. M., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2649 · Cited by 1,197
Cited by
Items 301–400 of 1,001
Wang, Y., Liu, Y., Li, J., Yang, Y., Ni, X., Cheng, H., Huang, T., Guo, Y., Ma, H., Zheng, P., et al. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27121 · Cited by 68
Exploring C-To-G Base Editing in Rice, Tomato, and Poplar
Sretenovic, S., Liu, S., Li, G., Cheng, Y., Fan, T., Xu, Y., Zhou, J., Zheng, X., Coleman, G. D., Zhang, Y., et al. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.756766 · Cited by 68
Genome editing technologies and their applications in crop improvement
Mishra, R., & Zhao, K. (2018) · Plant Biotechnology Reports · doi:10.1007/s11816-018-0472-0 · Cited by 78
McGrath, E., Shin, H., Zhang, L., Phue, J.-N., Wu, W. W., Shen, R.-F., Jang, Y.-Y., Revollo, J., & Ye, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-13342-8 · Cited by 62
CRISPR–Cas9D10A nickase‐assisted base editing in the solvent producer Clostridium beijerinckii
Li, Q., Seys, F. M., Minton, N. P., Yang, J., Jiang, Y., Jiang, W., & Yang, S. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26949 · Cited by 67
DddA homolog search and engineering expand sequence compatibility of mitochondrial base editing
Li, M., Shi, M., Li, Y., Xie, G., Rao, X., Wu, D., Cheng, A., Niu, M., Xu, F., Yu, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36600-2 · Cited by 68
Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9
Choi, G. C. G., Zhou, P., Yuen, C. T. L., Chan, B. K. C., Xu, F., Bao, S., Chu, H. Y., Thean, D., Tan, K., Wong, K. H., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0473-0 · Cited by 63
Efficient generation of Knock-in/Knock-out marmoset embryo via CRISPR/Cas9 gene editing
Kumita, W., Sato, K., Suzuki, Y., Kurotaki, Y., Harada, T., Zhou, Y., Kishi, N., Sato, K., Aiba, A., Sakakibara, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49110-3 · Cited by 67
Multiple gene substitution by Target-AID base-editing technology in tomato
Hunziker, J., Nishida, K., Kondo, A., Kishimoto, S., Ariizumi, T., & Ezura, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-77379-2 · Cited by 61
Self-citationHighly efficient C‐to‐T and A‐to‐G base editing in a Populus hybrid
Li, G., Sretenovic, S., Eisenstein, E., Coleman, G. D., & Qi, Y. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13581 · Cited by 64
Yang, L., Zhang, X., Wang, L., Yin, S., Zhu, B., Xie, L., Duan, Q., Hu, H., Zheng, R., Wei, Y., et al. (2019) · Protein & Cell · doi:10.1007/s13238-019-0631-2 · Cited by 61
CRISPR-Cas gene editing technology and its application prospect in medicinal plants
Guo, M., Chen, H., Dong, S., Zhang, Z., & Luo, H. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00584-w · Cited by 68
Mammalian Synthetic Biology: Engineering Biological Systems
Black, J. B., Pérez‐Piñera, P., & Gersbach, C. A. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044649 · Cited by 63
Beyond editing to writing large genomes
Chari, R., & Church, G. M. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.59 · Cited by 63
CRISPR system: Discovery, development and off-target detection
Chen, S., Yao, Y., Zhang, Y., & Fan, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109577 · Cited by 60
Prime Editing Technology and Its Prospects for Future Applications in Plant Biology Research
Hassan, M. M., Yuan, G., Chen, J., Tuskan, G. A., & Yang, X. (2020) · BioDesign Research · doi:10.34133/2020/9350905 · Cited by 69
Delivery Approaches for Therapeutic Genome Editing and Challenges
Ates, I., Rathbone, T., Stuart, C., Bridges, P. H., & Cottle, R. N. (2020) · Genes · doi:10.3390/genes11101113 · Cited by 63
Imkeller, K., Ambrosi, G., Boutros, M., & Huber, W. K. (2020) · Genome biology · doi:10.1186/s13059-020-1939-1 · Cited by 75
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
Liu, N., Zhou, L., Lin, G., Hu, Y., Jiao, Y., Wang, Y., Liu, J., Yang, S., & Yao, S. (2022) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2022.05.036 · Cited by 58
Current status and trends in forest genomics
Borthakur, D., Busov, V. B., Cao, H. X., Du, Q., Gailing, O., Işik, F., Ko, J., Li, C., Li, Q., Niu, S., et al. (2022) · Forestry Research · doi:10.48130/fr-2022-0011 · Cited by 68
Epigenome editing for targeted DNA (de)methylation: a new perspective in modulating gene expression
Seem, K., Kaur, S., Kumar, S., & Mohapatra, T. (2024) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2024.2320659 · Cited by 69
Kim, H. S., Kweon, J., & Kim, Y. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01212-3 · Cited by 90
CRISPR/Cas9-mediated genome editing in plants
Liu, X., Xie, C., Si, H., & Yang, J. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.009 · Cited by 68
Advances in Genome Editing and Application to the Generation of Genetically Modified Rat Models
Chenouard, V., Remy, S., Tesson, L., Ménoret, S., Ouisse, L.-H., Cherifi, Y., & Anegon, I. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.615491 · Cited by 57
Highly efficient base editing in human tripronuclear zygotes
Zhou, C., Zhang, M., Wei, Y., Sun, Y., Sun, Y., Pan, H., Yao, N., Zhong, W., Li, Y., Li, W., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0459-6 · Cited by 56
Recent advances in CRISPR/Cas9 and applications for wheat functional genomics and breeding
Li, J., Li, Y., & Ma, L. (2021) · aBIOTECH · doi:10.1007/s42994-021-00042-5 · Cited by 69
The Role of Recombinant AAV in Precise Genome Editing
Bijlani, S., Pang, K. M., Sivanandam, V., Singh, A., & Chatterjee, S. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.799722 · Cited by 68
Predicting base editing outcomes using position-specific sequence determinants
Pallaseni, A., Peets, E. M., Koeppel, J., Weller, J., Vanderstichele, T., Ho, U. L., Crepaldi, L., van Leeuwen, J. S., Allen, F., & Parts, L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac161 · Cited by 62
Biswas, S., Bridgeland, A., Irum, S., Thomson, M. J., & Septiningsih, E. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179809 · Cited by 62
Klompe, S. E., & Sternberg, S. H. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0012 · Cited by 59
CRISPR-Based Tools in Immunity
Simeonov, D. R., & Marson, A. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041522 · Cited by 63
Bae, S., Park, B. G., Kim, B., & Hahn, J. (2019) · Biotechnology Journal · doi:10.1002/biot.201900238 · Cited by 57
BEAT: A Python program to quantify base editing from Sanger sequencing
Xu, L., Liu, Y., & Han, R. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0017 · Cited by 56
Advances on systems metabolic engineering of Bacillus subtilis as a chassis cell
Xiang, M., Kang, Q. K., & Zhang, D. (2020) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2020.07.005 · Cited by 64
CRISPR-induced indels and base editing using the Staphylococcus aureus Cas9 in potato
Veillet, F., Kermarrec, M.-P., Chauvin, L., Chauvin, J.-E., & Nogué, F. (2020) · PLOS ONE · doi:10.1371/journal.pone.0235942 · Cited by 55
Genome Editing for Improving Crop Nutrition
Nagamine, A., & Ezura, H. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.850104 · Cited by 66
Design principles for nuclease-deficient CRISPR-based transcriptional regulators
Jensen, M. K. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy039 · Cited by 60
Wang, X., & Musunuru, K. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.008 · Cited by 58
CRISPR/Cas9 Gene Editing: An Unexplored Frontier for Forest Pathology
Dort, E. N., Tanguay, P., & Hamelin, R. C. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.01126 · Cited by 62
Cytosine base editing systems with minimized off-target effect and molecular size
Li, A., Mitsunobu, H., Yoshioka, S., Suzuki, T., Kondo, A., & Nishida, K. (2022) · Nature Communications · doi:10.1038/s41467-022-32157-8 · Cited by 60
Self-citationJann, C., Giofrè, S., Bhattacharjee, R., & Lemke, E. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00878 · Cited by 55
Genetically-engineered mouse models of small cell lung cancer: the next generation
Oser, M. G., MacPherson, D. P., Oliver, T. G., Sage, J., & Park, K.-S. (2024) · Oncogene · doi:10.1038/s41388-023-02929-7 · Cited by 57
Emerging trends in prime editing for precision genome editing
Lee, J., Kweon, J., & Kim, Y. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01463-8 · Cited by 75
Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease
Kato, M. V. (2018) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2018.37.3.197 · Cited by 58
Adenovirus vectors in hematopoietic stem cell genome editing
Li, C., & Lieber, A. (2019) · FEBS Letters · doi:10.1002/1873-3468.13668 · Cited by 58
Catalytic-state structure and engineering of Streptococcus thermophilus Cas9
Zhang, Y., Zhang, H., Xu, X., Wang, Y., Chen, W., Wang, Y., Wu, Z., Tang, N., Wang, Y., Zhao, S., et al. (2020) · Nature Catalysis · doi:10.1038/s41929-020-00506-9 · Cited by 51
DNA base editing in nuclear and organellar genomes
Tan, J., Forner, J., Karcher, D., & Bock, R. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.06.015 · Cited by 61
CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants
Abdullah, Jiang, Z., Hong, X., Zhang, S., Yao, R., & Xiao, Y. (2020) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2020.08.003 · Cited by 53
CRISPR-derived genome editing technologies for metabolic engineering
Nishida, K., & Kondo, A. (2020) · Metabolic Engineering · doi:10.1016/j.ymben.2020.12.002 · Cited by 57
Self-citationGenome- and transcriptome-wide off-target analyses of an improved cytosine base editor
Randall, L. B., Sretenovic, S., Wu, Y., Yin, D., Zhang, T., Eck, J. V., & Qi, Y. (2021) · Plant Physiology · doi:10.1093/plphys/kiab264 · Cited by 51
In the business of base editors: Evolution from bench to bedside
Porto, E. M., & Komor, A. C. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002071 · Cited by 57
Genome Editing of Plant Mitochondrial and Chloroplast Genomes
Arimura, S., & Nakazato, I. (2023) · Plant and Cell Physiology · doi:10.1093/pcp/pcad162 · Cited by 58
Targeted Nucleotide Editing Technologies for Microbial Metabolic Engineering
Arazoe, T., Kondo, A., & Nishida, K. (2018) · Biotechnology Journal · doi:10.1002/biot.201700596 · Cited by 55
Self-citationMolla, K. A., Shih, J., & Yang, Y. (2020) · aBIOTECH · doi:10.1007/s42994-020-00018-x · Cited by 51
Sretenovic, S., Yin, D., Levav, A., Selengut, J. D., Mount, S. M., & Qi, Y. (2021) · Plant Communications · doi:10.1016/j.xplc.2020.100101 · Cited by 52
A CRISPR way for accelerating cereal crop improvement: Progress and challenges
Basu, U., Riaz Ahmed, S., Bhat, B. A., Anwar, Z., Ali, A., Ijaz, A., Gulzar, A., Bibi, A., Tyagi, A., Nebapure, S. M., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.866976 · Cited by 51
“Activation-induced cytidine deaminase is another base editing method and Target-AID was developed and is composed of a cytidine deaminase pmCDA1 (from the southern eel) and a nickase (Cas9D10A) (Nishida et al., 2016).”
MethodKawaguchi, K., Takei-Hoshi, R., Yoshikawa, I., Nishida, K., Kobayashi, M., Kusano, M., Lu, Y., Ariizumi, T., Ezura, H., Otagaki, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00966-4 · Cited by 59
Self-citationBase editing in human cells with monomeric DddA-TALE fusion deaminases
Mok, Y. G., Lee, J. M., Chung, E., Lee, J., Lim, K., Cho, S.-I., & Kim, J. (2022) · Nature Communications · doi:10.1038/s41467-022-31745-y · Cited by 52
Towards the Clinical Application of Gene Therapy for Genetic Inner Ear Diseases
Lahlou, G., Calvet, C., Giorgi, M., Lecomte, M.-J., & Safieddine, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031046 · Cited by 57
Efficient plant genome engineering using a probiotic sourced CRISPR-Cas9 system
Zhong, Z., Liu, G., Tang, Z., Xiang, S., Yang, L., Huang, L., He, Y., Fan, T., Liu, S., Zheng, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41802-9 · Cited by 59
APOBEC3 induces mutations during repair of CRISPR–Cas9-generated DNA breaks
Lei, L., Chen, H., Xue, W., Yang, B., Hu, B., Wei, J., Wang, L., Cui, Y., Li, W., Wang, J., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0004-6 · Cited by 54
Reprogramming Acetogenic Bacteria with CRISPR-Targeted Base Editing via Deamination
Xia, P., Casini, I., Schulz, S., Klask, C.-M., Angenent, L. T., & Molitor, B. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00226 · Cited by 50
Kim, S., Choi, M., Bae, S., & Kim, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111389 · Cited by 54
Modern therapeutic approaches to liver-related disorders
Gardin, A., Remih, K., Gonzales, E. M., Andersson, E. R., & Strnad, P. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.015 · Cited by 51
Sufyan, M., Daraz, U., Hyder, S., Zulfiqar, U., Iqbal, R., Eldin, S. M., Rafiq, F., Mahmood, N., Shahzad, K., Uzair, M., et al. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01036-w · Cited by 60
Base Editing Landscape Extends to Perform Transversion Mutation
Molla, K. A., Qi, Y., Karmakar, S., & Baig, M. J. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.09.001 · Cited by 54
Base editors: Expanding the types of DNA damage products harnessed for genome editing
Gu, S., Bodai, Z., Cowan, Q. T., & Komor, A. C. (2021) · Gene and Genome Editing · doi:10.1016/j.ggedit.2021.100005 · Cited by 50
“[21,22] Additionally, C•G to G•C base editors (CGBEs) have been developed by fusing the UNG Gu et al.”
MethodDevelopment of an efficient plant dual cytosine and adenine editor
Xu, R., Kong, F., Qin, R., Li, J., Liu, X., & Wei, P. (2021) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13146 · Cited by 52
Guyon, A., Rousseau, J., Bégin, F.-G., Bertin, T., Lamothe, G., & Tremblay, J. P. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.02.032 · Cited by 57
The expanded CRISPR toolbox for constructing microbial cell factories
Teng, Y., Jiang, T., & Yan, Y. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.06.012 · Cited by 55
Chen, J., Cai, Z., Bai, M., Yu, X., Zhang, C., Cao, C., Hu, X., Wang, L., Su, R., Wang, D., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0076-9 · Cited by 49
CRISPR-Assisted Multiplex Base Editing System in Pseudomonas putida KT2440
Sun, J. F., Lu, L., Liang, T., Yang, L.-R., & Wu, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00905 · Cited by 52
Lyu, P., Lu, Z., Cho, S.-I., Yadav, M., Yoo, K. W., Atala, A., Kim, J., & Lu, B. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0095 · Cited by 50
Advances and Perspectives for Genome Editing Tools of Corynebacterium glutamicum
Wang, Q., Zhang, J., Makishah, N. H. A., Sun, X., Wen, Z., Jiang, Y., & Yang, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.654058 · Cited by 49
Highly efficient base editing with expanded targeting scope using SpCas9‐NG in rabbits
Liu, Z., Shan, H., Chen, S., Chen, M., Song, Y., Lai, L., & Li, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201901587r · Cited by 47
Precise A•T to G•C base editing in the zebrafish genome
Qin, W., Lu, X., Liu, Y., Bai, H., Li, S., & Lin, S. (2018) · BMC Biology · doi:10.1186/s12915-018-0609-1 · Cited by 47
Editing the Central Nervous System Through CRISPR/Cas9 Systems
Cota-Coronado, A., Díaz-Martínez, N. F., Padilla‐Camberos, E., & Diaz-Martinez, N. E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00110 · Cited by 56
O’Brien, A. R., Wilson, L. O. W., Burgio, G., & Bauer, D. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-39142-0 · Cited by 54
Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing
Hanson, B., Wood, M. J. A., & Roberts, T. C. (2021) · RNA Biology · doi:10.1080/15476286.2021.1874161 · Cited by 54
Plant genome editing: ever more precise and wide reaching
Sukegawa, S., Saika, H., & Toki, S. (2021) · The Plant Journal · doi:10.1111/tpj.15233 · Cited by 48
Genome editing in the treatment of ocular diseases
Choi, E. H., Suh, S., Sears, A. E., Hołubowicz, R., KEDHAR, S. R., Browne, A., & Palczewski, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01057-2 · Cited by 57
Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries
Ong, S. H., Li, Y., Koike-Yusa, H., & Yusa, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-07827-z · Cited by 45
Multiplex nucleotide editing by high-fidelity Cas9 variants with improved efficiency in rice
Xu, W., Song, W., Yang, Y., Wu, Y., Lv, X., Yuan, S., Liu, Y., & Yang, J. (2019) · BMC Plant Biology · doi:10.1186/s12870-019-2131-1 · Cited by 47
Current trends in gene recovery mediated by the CRISPR-Cas system
Jang, H., Song, B., Hwang, G., & Bae, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0466-1 · Cited by 52
Nakajima, K., Zhou, Y., Tomita, A., Hirade, Y., Gurumurthy, C. B., & Nakada, S. (2018) · Genome Research · doi:10.1101/gr.226027.117 · Cited by 47
Efficient Correction of a Hypertrophic Cardiomyopathy Mutation by ABEmax-NG
Ma, S., Jiang, W., Liu, X., Lu, W., Qi, T., Wei, J., Wu, F., Chang, Y., Zhang, S., Song, Y., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.318674 · Cited by 47
Ali, Q., Yu, C., Hussain, A., Ali, M., Ahmar, S., Sohail, M. A., Riaz, M., Ashraf, M. F., Abdalmegeed, D., Wang, X., et al. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.860281 · Cited by 58
New advances in CRISPR/Cas-mediated precise gene-editing techniques
Richardson, C., Kelsh, R. N., & Richardson, R. J. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049874 · Cited by 57
Base editing of organellar DNA with programmable deaminases
Kim, J., & Chen, J. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00663-2 · Cited by 49
CRISPR/Cas system: A game changing genome editing technology, to treat human genetic diseases
Hussain, W., Mahmood, T., Hussain, J. S., Ali, N., Shah, T. M., Qayyum, S., & Khan, I. (2018) · Gene · doi:10.1016/j.gene.2018.10.072 · Cited by 47
CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors
Lee, C., Hyun Jo, D., Hwang, G.-H., Yu, J., Kim, J. H., Park, S.-E., Kim, J.-S., Kim, J. H., & Bae, S. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.013 · Cited by 46
Dandage, R., Després, P. C., Yachie, N., & Landry, C. R. (2019) · Genetics · doi:10.1534/genetics.119.302089 · Cited by 48
Self-citationMultiplex genome editing using a dCas9-cytidine deaminase fusion in Streptomyces
Zhao, Y., Tian, J., Zheng, G., Chen, J., Sun, C., Yang, Z., Zimin, A. A., Jiang, W., Deng, Z., Wang, Z., et al. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1559-y · Cited by 52
CRISPR/Cas9-deaminase enables robust base editing in Rhodobacter sphaeroides 2.4.1
Luo, Y., Ge, M., Wang, B., Sun, C., Wang, J., Dong, Y., & Xi, J. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01345-w · Cited by 46
From Genome Sequencing to CRISPR-Based Genome Editing for Climate-Resilient Forest Trees
Cao, H. X., Vu, G. T. H., & Gailing, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020966 · Cited by 60
C-to-G editing generates double-strand breaks causing deletion, transversion and translocation
Huang, M. E., Qin, Y., Shang, Y., Hao, Q., Zhan, C., Lian, C., Luo, S., Liu, L. D., Zhang, S., Zhang, Y., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-023-01342-2 · Cited by 48
Application of CRISPR/Cas9-mediated gene editing for the development of herbicide-resistant plants
Han, Y., & Kim, J. (2019) · Plant Biotechnology Reports · doi:10.1007/s11816-019-00575-8 · Cited by 45
Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
Yu, W., & Wu, Z. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.011 · Cited by 50
CRISPR‐BETS: a base‐editing design tool for generating stop codons
Wu, Y., He, Y., Sretenovic, S., Liu, S., Cheng, Y., Han, Y., Liu, G., Bao, Y., Fang, Q., Zheng, X., et al. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13732 · Cited by 46
Hillary, V. E., & Ceasar, S. A. (2022) · BioEssays · doi:10.1002/bies.202200032 · Cited by 45
Metadata
- Authors
- Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., Shimatani, Z., & Kondo, A.
- Affiliations
- Kobe University (JP)
- Keio University (JP)
- Shizuoka University (JP)
- Corresponding author
- Kondo, Akihiko
- ORCID
- Venue
- Science
- Published
- 2016-09-16
- Volume
- 353
- Issue
- 6305
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2480829753
- Cited by
- 1,349
- References
- 27
- Citations by year
- 2026: 69 · 2025: 124 · 2024: 151 · 2023: 152 · 2022: 181 · 2021: 157 · 2020: 167 · 2019: 137 · 2018: 112 · 2017: 88 · 2016: 10
- FWCI
- 60.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports and Technology (MEXT) of Japan
- Ministry of Economy, Trade and Industry (METI), Japan
- JSPS KAKENHI (26119710, 16K14654)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- activation-induced cytidine deaminase, CRISPR/Cas9, dCas9, sea lamprey, somatic hypermutation, R-loops, site-directed mutagenesis, genome editing, immunoglobulin variable region, affinity maturation
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, AICDA (Activation-Induced Cytidine Deaminase), Alleles, Animals, Bacteria, Bacterial Proteins, Cricetulus, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, Endonucleases, Enzyme Inhibitors, Immune System, RNA, Saccharomyces cerevisiae, Vertebrates, CHO Cells, Point Mutation, Gene Targeting, Uracil-DNA Glycosidase, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.